| ANAVEX LIFE SCIENCES CORP. (AVXL) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2021-Mar-31 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | ||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q2-FY2021 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | ||||||||||||||
| Price to Sales | 73.15x | 163.41x | 144.67x | 118.29x | 135.98x | 65.92x | 47.51x | 55.25x | 1,635.17x | 1,381.05x | 1,486.93x | 931.79x | 824.87x | 803.93x | 662.90x | 432.47x | 237.91x | 486.21x | 554.89x | 979.91x | 1,238.21x | 1,981.80x | |||||||||||||||||||||||||||
| Price to Book | 3.61x | 8.06x | 8.65x | 7.30x | 8.22x | 4.01x | 2.75x | 3.09x | 16.01x | 16.58x | 21.12x | 11.55x | 6.85x | 9.83x | 11.63x | 7.29x | 5.57x | 8.21x | 9.36x | 8.21x | 3.71x | 5.56x | 4.96x | 5.46x | 5.57x | 6.75x | |||||||||||||||||||||||
| Price to Earnings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||
| Debt to Asset Ratio | .09x | .11x | .15x | .11x | .11x | .08x | .07x | .08x | .08x | .09x | .21x | .20x | .17x | .20x | .20x | .16x | .12x | .15x | .12x | .13x | .10x | .13x | .06x | .09x | .10x | .34x | .22x | .20x | .18x | .17x | .18x | .26x | .93x | .97x | .20x | .18x | 12.07x | ||||||||||||
| Current Ratio | 5.03x | 5.03x | 3.23x | 4.53x | 6.71x | 8.33x | 7.55x | 10.11x | 7.75x | 17.09x | 11.11x | 9.71x | 2.96x | 4.53x | 4.98x | 5.54x | 5.81x | 5.90x | 4.16x | 4.97x | 5.10x | 4.31x | 4.90x | .08x | |||||||||||||||||||||||||